Key Highlights
- NBIS shares climbed approximately 8.95% intraday, reaching a new 52-week peak of $179.96
- The company announced a roughly $643 million acquisition of Eigen AI to enhance its Token Factory AI capabilities
- A massive $27 billion partnership with Meta elevated the firm’s total contracted backlog close to $50 billion
- Goldman Sachs upgraded its price target post-Meta announcement; analyst consensus stands at “Moderate Buy” with $154.75 average target
- Next earnings report scheduled for May 13 (Q1 2026), with focus on ARR metrics and Eigen integration updates
Shares of Nebius Group (NBIS) began trading Wednesday at $175.92, climbing to an intraday high of $179.96—a 52-week record—representing an approximately 9% gain for the session. The stock has surged more than 110% since the start of the year.
This explosive movement follows two significant announcements arriving nearly simultaneously—a $643 million transaction to acquire Eigen AI and a landmark $27 billion agreement with Meta.
The Eigen AI transaction aims to integrate advanced model-optimization and inference technologies into Nebius’s Token Factory infrastructure. Market observers suggest this acquisition could enhance profit margins while positioning the company to capture a more substantial portion of production-scale AI computing demand.
The Meta agreement represents the larger catalyst. Combined with previously announced partnerships including Microsoft, this single contract has elevated Nebius’s total contracted backlog to approximately $50 billion—a figure that has captured significant attention across investment communities.
Goldman Sachs responded swiftly by increasing its NBIS price target following the Meta announcement. BWS Financial and DA Davidson have both established $200 price objectives with Buy recommendations. Cantor Fitzgerald launched coverage with an Overweight stance, though at a more measured $129 target. Overall analyst consensus reflects a “Moderate Buy” rating with a mean price target of $154.75.
Institutional capital has been flowing into the stock as well. Millennium Management established a fresh position valued at approximately $11.6 million during Q1. UBS added roughly $9 million to its holdings. Oppenheimer increased its stake by 90.9% in Q4. Combined institutional ownership currently stands at about 21.9% of outstanding shares.
Understanding the Backlog Momentum
The approximately $50 billion in contracted backlog forms the foundation of the bullish investment thesis. Multi-year agreements with hyperscale cloud providers like Meta and Microsoft provide revenue predictability extending through 2026, when management has projected revenues between $3.0 and $3.4 billion.
This level of forward revenue visibility is uncommon in the sector and represents a primary driver behind momentum traders pushing shares to unprecedented levels.
Potential Headwinds to Consider
Not all metrics paint an entirely positive picture. Operating cash flow for fiscal year 2025 totaled approximately $402 million—however, this figure incorporated nearly $983 million in customer advance payments. Excluding these advances reveals a considerably leaner cash generation profile.
Company leadership has disclosed that contracted cash inflows will satisfy only about 60% of projected 2026 capital expenditure needs. This funding shortfall raises legitimate concerns regarding potential equity dilution or additional debt financing requirements.
Insider selling activity has also accelerated. Chief Technology Officer Danila Shtan divested over 13,000 shares in late March. Insider Andrey Korolenko sold more than 31,000 shares in early April. Collectively, company insiders have sold approximately 135,622 shares valued at over $15.6 million during the past three months.
The equity also exhibits a beta coefficient of 4.03—indicating extreme volatility in both directions. With projected full-year earnings per share of -$2.44 and a PE ratio of -120.49, current valuation metrics rely entirely on forward growth expectations.
The company’s Q1 2026 earnings report is scheduled for May 13. Investors will scrutinize annual recurring revenue growth, progress updates on hyperscaler deployments, and preliminary indicators regarding the Eigen AI integration roadmap.



